TELO
Telomir Pharmaceuticals, Inc.
1.20$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | +558.7% | +88.9% | +42.0% | +9.0% | |
| – | +79.9% | +2,766.1% | +1,505.5% | -15.9% | |
| – | +518.4% | +361.5% | +210.6% | -13.9% | |
| – | – | – | – | – | |
| – | – | – | +164.1% | -100.0% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | -21,794.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.